FDA Risk Evaluation and Mitigation Strategies (REMS): Description and Effect on Generic Drug Development
Full report
What this is
The Congressional Research Service is a nonpartisan policy and legal analysis arm of the Library of Congress. CRS reports are written for members of Congress and their staff, not the public — but they’re made available openly through Congress.gov.
- HR 2841114th Congress
FAST Generics Act of 2015
Jun 19, 2015 · Referred to the Subcommittee on Health.
- S 3056114th Congress
CREATES Act of 2016
Jun 21, 2016 · Committee on the Judiciary Subcommittee on Antitrust, Competition Policy and Consumer Rights. Hearings held.
- HR 2051115th Congress
FAST Generics Act of 2017
Apr 7, 2017 · Referred to the Subcommittee on Health.
- HR 2212115th Congress
CREATES Act of 2017
Apr 28, 2017 · Referred to the Subcommittee on Health.
- HR 2430115th Congress
FDA Reauthorization Act of 2017
Aug 18, 2017 · Signed by President.
- S 974115th Congress
Creating and Restoring Equal Access to Equivalent Samples Act of 2018
Jun 21, 2018 · Placed on Senate Legislative Calendar under General Orders. Calendar No. 482.